← Leaderboards
Gerhard Walzl
Stellenbosch University
$3,997,795
Attributed
$10,348,627
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2018–25$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,348,627 · 2
By mechanism
U01$7,059,114 · 1
R01$3,289,513 · 1
Top collaborators
- John T Belisle5 shared
- David M. Lewinsohn5 shared
- Jayne Sutherland5 shared
Most similar at Stellenbosch University
Same institution · by research overlap
- John T Belisle$22,161,703
- Jayne Sutherland$2,353,038
- James Alexander Seddon$4,133,107
Others in their field
Other Emerging Leaders on “Blood”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
Research focus
BloodTuberculosisProteinsHealth StatusHiv InfectionsCohortEarly DiagnosisInfectionBaseAdultBacteriaAffectBindingAnabolismClone CellsAsiaCessation Of LifeAreaAgonistChestChildClinical ResearchClinical Research SiteCells
Grant awards (10)
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)$1,059,114
U01 · FY2025 · AI · contact PI
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)$1,500,000
U01 · FY2024 · AI · contact PI
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)$1,500,000
U01 · FY2023 · AI · contact PI
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis$672,512
R01 · FY2022 · AI
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)$1,500,000
U01 · FY2021 · AI · contact PI
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis$683,274
R01 · FY2021 · AI
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)$1,500,000
U01 · FY2020 · AI · contact PI
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis$604,694
R01 · FY2020 · AI
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis$641,858
R01 · FY2019 · AI
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis$687,175
R01 · FY2018 · AI